期刊文献+

223例非小细胞肺癌骨转移发生骨相关事件的临床因素与预后 被引量:5

Clinical factors and prognostic significance of skeletal related events in bone metastasis of non small cell lung cancer in 223 cases
下载PDF
导出
摘要 目的研究非小细胞肺癌(NSCLC)骨转移发生骨相关事件(SREs)的风险因素及其对患者预后的影响。方法回顾性研究2010-2012年该院223例NSCLC骨转移患者的临床特征,用单因素分析和多因素分析对SREs的预测因素分析。结果223例NSCLC骨转移患者中,发生SREs患者为119例(53.4%)。单因素分析显示女性、无吸烟史、腺癌、单发骨转移病灶患者发生SREs风险低于男性、吸烟史、非腺癌、多发骨转移病灶患者,差异有统计学意义(P〈0.05),其余各项差异无统计学意义(P〉0.05)。多因素分析显示多发骨转移是发生SREs的独立风险因素。NSCLC骨转移患者的中位生存时间为15.3个月,生存分析显示NSCLC骨转移患者发生SREs对预后无显著影响(P〉0.05)。结论 NSCLC骨转移患者中,女性、腺癌、不吸烟史、单发骨转移病灶患者发生SREs风险更低,多发骨转移是发生SREs的独立风险因素,应注意监测和预防。 Objective To explore the risk factors of skeletal related events(SREs)in non small cell lung cancer with bone metastases and its effect on the prognosis.Methods Totally 223 cases of NSCLC patients with bone metastasis were retrospective studied from January 2010 to December 2012 in our hospital.The clinical features,predictive factors for SREs were analysed by single factor and multifactor analysis.Results Among 223 cases of NSCLC patients with bone metastasis,119 cases occured with SREs(53.4%).Univariate analysis showed that the occurrence of SREs in female,no smoker,adenocarcinoma,solitary bone metastasis lesions were less than the male,smoker non-adenocarcinoma,and multiple bone metastases(P〈0.05),but the rost without statistically significant(P〈0.05).The multivariate analysis revealed only multiple bone metastases was an independent risk factor for SREs.The median survival time of the NSCLC patients with bone metastasis was 15.3 months.Moreover,survival analysis showed that SREs had no statistical significance on the prognosis of bone metastasis in NSCLC patients(P〈0.05).ConclusionThe female,adenocarcinoma,smoking history,solitary bone metastasis lesions occurred in patients with lower risk SREs.Multiple bone metastasis is an independent risk factor for SREs,attention should be paid to monitoring and prevention.
出处 《重庆医学》 CAS 北大核心 2015年第32期4504-4506,共3页 Chongqing medicine
基金 国家自然科学基金资助项目(81171904) 第三军医大学重大临床研究基金(2015001)
关键词 非小细胞肺 骨转移 骨相关事件 cancer non small cell lung bone metastasis skeletal related events
  • 相关文献

参考文献13

  • 1Coleman RE. Skeletal complications of malignancy[J]. Cancer, 1997,80(8 Suppl) :S1588-1594. 被引量:1
  • 2Delea T,Langer C, McKiernan J, et al. The cost of treat- ment of skeletal-related events in patients with bone me tastases from lung cancer[J]. Oncology, 2004,67 (5/6) :390-396. 被引量:1
  • 3Saad F,Lipton A,Cook R,et al. Pathologic fractures cor- relate with reduced survival in patients with malignant bone disease[J]. Cancer,2007,110(8):1860-1867. 被引量:1
  • 4沈玉萍,韩宝惠,许青,王慧敏,邱慧敏,顾爱琴.非小细胞肺癌骨转移的临床与预后分析[J].第二军医大学学报,2009,30(9):1043-1047. 被引量:15
  • 5Sandler A, Gray R, Perry MC, et aI. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer [J]. N Engl J Med,2006,355(24):2542-2550. 被引量:1
  • 6Lipton A, Cook R, Brown J, et al. Skeletal-related events and clinical outcomes in patients with bone metastases and normal levels of osteolysis: exploratory analyses[J]. Clin Oncol (R Coil Radiol) ,2013,25(4) :217-226. 被引量:1
  • 7Sun JM, Ahn JS, Lee S, et al. Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases[J]. Lung Cancer, 2011,71 (1) : 89-93. 被引量:1
  • 8Rosen LS, Gordon D, Tehekmedyian S, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial-the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group [J]. J Clin Oncol,2003,21(16) :3150-3157. 被引量:1
  • 9De Marinis F, Eberhardt W, Harper PG, et al. Bisphos- phonate use in patients with lung cancer and bone metas- tases:recommendations of a European expert panel[J]. J Thorac Oncol,2009,4(10) :1280-1288. 被引量:1
  • 10Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies [J]. Cancer Treat Rev,2001,27(3):165-176. 被引量:1

二级参考文献19

  • 1Claire B. POLLOCK,Kathleen KELLY.Mechanisms of cancer metastasis to the bone[J].Cell Research,2005,15(1):57-62. 被引量:54
  • 2余靖,邸立军,宛凤玲,勇威本.骨代谢生化指标诊断恶性肿瘤骨转移的临床意义[J].中国肿瘤临床,2005,32(20):1193-1196. 被引量:10
  • 3高云,方健,刘叙仪,林宝和,安彤同,高非.305例非小细胞肺癌骨转移的诊断、治疗及预后分析[J].中国肺癌杂志,2006,9(4):357-361. 被引量:18
  • 4Coleman R E. Metastatic bone disease: clinical features, pathophysiology and treatment strategies[J]. Cancer Treat Rev, 2001,27:165- 176. 被引量:1
  • 5Wilson M A,Calhoun F W. The distribution of skeletal metastases in breast and pulmonary cancer: concise communication [J].J Nucl Med,1981,22:594-597. 被引量:1
  • 6Coleman R E. Skeletal complications of malignancy[J].Cancer, 1997,80(8 Suppl) : 1588-1594. 被引量:1
  • 7Ohashi R, Takahashi K, Miura K, Ishiwata T, Sakuraba S, Fukuchi Y. Prognostic factors in patients with inoperable non- small cell lung cancer-an analysis of long-term survival patients [J]. Gan To Kagaku Ryoho, 2006,33 : 1595-1602. 被引量:1
  • 8Albain K S, Crowley J J, LeBlane M, Livingston R B. Survival determinants in extensive stage non-small cell lung cancer: the Southwest Oncology Group experience[J]. J Clin Oncol, 1991, 9:1618 -1626. 被引量:1
  • 9Vinolas N,Molina R,Galan M C,Casas F,Callejas M A,Filella X,et al. Tumor markers in response monitoring and prognosis of non small cell lung cancer:preliminary report[J]. Anticancer Res,1998,18(1B) :631- 634. 被引量:1
  • 10Merrick M V,Merrick J M. Bone scintigraphy in lung cancer:a reappraisal[J]. Br J Radiol, 1986,59: 1185 1194. 被引量:1

共引文献25

同被引文献67

引证文献5

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部